Such data lead some authors to conclude that SIRT3 is an oncogene in cancers that are addicted to OXPHOS, and conversely, SIRT3 is a tumor suppressor in glycolysis-dependent cancers because it could activate glucose assimilation by mitochondria [142]. The gene discussed is SIRT3; the disease is neoplasm.